White Willow Bark: Inactive Ingredient

 

White willow bark (Salix alba) comes from a deciduous tree native to Europe and Western Asia and has been referenced in traditional botanical use for thousands of years. Historical records show its use in ancient Egypt, classical Greece, and early Chinese medicine, as well as among Indigenous communities in North America.

In 1763, English clergyman Edward Stone formally documented white willow bark in a report to the Royal Society. In 1828, the compound salicin was isolated from the bark, contributing to later scientific developments that eventually led to the creation of aspirin in the late 19th century. Despite these pharmaceutical advancements, white willow bark has continued to hold a place in European herbal traditions.

Today, white willow bark is recognized for its naturally occurring salicin and related plant compounds. At Faeve, we include this botanical with respect for both its long-standing heritage and its role in the evolution of modern plant-based and pharmaceutical science. As with all of our ingredients, it is selected and formulated within established regulatory and safety standards.